Glucagon analogues
US8642541B2 · kind B2 · utility
26Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2008 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Dec 15, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes, metabolic syndrome and associated disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.